文献速递肺栓塞与肺血管病

非大面积中心性与非中心性肺栓塞的临床预后:一项注册登记队列研究

Clinical Prognosis of Nonmassive Central and Noncentral Pulmonary Embolism: A Registry-Based Cohort Study.
PubMed 文献 · Chest · 2016-11-19

基于RIETE注册登记中6674例CT确诊的症状性非大面积肺栓塞患者,比较中心性与非中心性肺栓塞的血栓复发、大出血和死亡风险。抗凝期间两组复发风险相似;停止抗凝后中心性肺栓塞复发风险边缘性升高,但仅限于非诱发性肺栓塞时该关联消失。

要点

  • 非大面积肺栓塞抗凝期间,中心性与非中心性肺栓塞的复发VTE、大出血和死亡风险相似。
  • 停止抗凝后中心性肺栓塞复发VTE风险边缘性升高(aHR 1.34,95%CI 1.01-1.78)。
  • 非诱发性肺栓塞中该关联不存在,抗凝时长不应依据栓塞部位决定。

核心结论

  • 非大面积肺栓塞中,中心性定位与停止抗凝后更高的复发VTE风险相关,但关联强度低且非诱发性肺栓塞中无此关联,临床意义有限。
  • 非大面积非诱发性肺栓塞的抗凝持续时间不应根据肺栓塞定位来调整。

研究设计与样本

  • 注册登记队列研究,纳入RIETE注册登记中经CT确诊的偶发症状性非大面积肺栓塞患者6674例。
  • 比较中心性肺栓塞(主肺动脉,占40.5%)与非中心性肺栓塞(更外周动脉)的复发VTE、大出血和死亡风险,采用Cox比例风险调整模型。

主要发现

  • 抗凝期间(5256.1患者年),中心性与非中心性肺栓塞的复发VTE风险相似(2.5 vs 2.1/100患者年;aHR 1.32;95%CI 0.91-1.90),大出血和死亡风险亦相似。
  • 停止抗凝后(2175.4患者年),中心性肺栓塞复发VTE风险边缘性高于非中心性(11.0 vs 8.0/100患者年;aHR 1.34;95%CI 1.01-1.78)。
  • 限制于非诱发性肺栓塞患者时,复发VTE风险无显著差异(13.8 vs 11.9/100患者年;aHR 1.15;95%CI 0.79-1.68;P = .48),大出血和死亡风险相似。

临床怎么用

  • 对于非大面积肺栓塞患者,不应仅根据栓塞位于中心或非中心来延长或缩短抗凝疗程。
  • 非诱发性非大面积肺栓塞停止抗凝后,需关注复发风险,但中心性定位不构成调整抗凝时长的依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Whether the localization of nonmassive pulmonary embolism (PE) is associated with the short-term and long-term prognosis of patients remains unknown. Our aim was to characterize associations of nonmassive PE localization with risks of recurrent VTE, major bleeding, and mortality during and after anticoagulation. METHODS: Among participants of the Registro Informatizado de la Enfermedad ThromboEmbòlica (RIETE) registry with incident symptomatic nonmassive PE diagnosed by CT scan, we compared risks of recurrent VTE, major bleeding, and mortality during and after anticoagulation between central PE (main pulmonary artery) and noncentral PE (more peripheral arteries) using Cox proportional hazard-adjusted models. RESULTS: Of the 6,674 participants, patients with central PE (40.5%) had age (mean 66 years), sex (46.9% male sex), and proportion of idiopathic (45.0%) and cancer-related (22.3%) PE that were similar to those of patients with noncentral PE. During anticoagulation (5,256.1 patient-years), the risk of recurrent VTE was similar between the two groups (2.5 vs 2.1 per 100 patient-years; adjusted hazard ratio [aHR], 1.32; 95% CI, 0.91-1.90), as were risks of major bleeding and mortality. After anticoagulation was discontinued (2,175.4 patient-years), participants with central PE had a borderline greater risk of recurrent VTE than did participants with noncentral PE (11.0 vs 8.0 per 100 patient-years; aHR, 1.34; 95% CI, 1.01-1.78) but not when restricted to participants after unprovoked PE (13.8 vs 11.9 per 100 patient-years; aHR, 1.15; 95% CI, 0.79-1.68; P = .48). Risks of major bleeding and mortality were similar. CONCLUSIONS: In nonmassive PE, central localization of PE is associated with greater risk of recurrent VTE after anticoagulation cessation. However, the low magnitude of this association and the absence of association after unprovoked PE suggest that the clinical relevance of this finding is limited and that the duration of anticoagulation should not be tailored to PE localization after nonmassive unprovoked PE.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Gouin B, Blondon M, Jiménez D, et al. Clinical Prognosis of Nonmassive Central and Noncentral Pulmonary Embolism: A Registry-Based Cohort Study. Chest. 2016. PMID: 27876590. doi:10.1016/j.chest.2016.10.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。